PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Ledermycin 150mg capsules
0501030F0BBAAAA
Ledermycin Demeclocycline hydrochloride Infections No data available
Ledermycin 300mg capsules
0501030F0BBABAJ
Ledermycin Demeclocycline hydrochloride Infections No data available
Ledipasvir 90mg / Sofosbuvir 400mg tablets
0503032F0AAAAAA
Ledipasvir/sofosbuvir Ledipasvir/sofosbuvir Infections No data available
Levamisole 25mg tablets
0505020L0AAAFAF
Levamisole hydrochloride Levamisole hydrochloride Infections No data available
Levofloxacin 100mg/ml nebuliser liquid ampoules
0501120X0AAAFAF
Levofloxacin Levofloxacin Infections No data available
Levofloxacin 500mg/100ml infusion bags
0501120X0AAADAD
Levofloxacin Levofloxacin Infections No data available
Levofloxacin 500mg/100ml infusion polyethylene bottles
0501120X0AAAGAG
Levofloxacin Levofloxacin Infections No data available
Levofloxacin 500mg/100ml solution for infusion bottles
0501120X0AAAEAE
Levofloxacin Levofloxacin Infections No data available
Levofloxacin 500mg/100ml solution for infusion vials
0501120X0AAACAC
Levofloxacin Levofloxacin Infections No data available
Linezolid 600mg/300ml infusion bags
0501070W0AAACAC
Linezolid Linezolid Infections No data available
Linezolid 600mg/300ml solution for infusion bottles
0501070W0AAADAD
Linezolid Linezolid Infections No data available
Lloydspharmacy Thrush Oral 150mg capsules
0502010B0BEAAAB
Lloydspharmacy (Fluconazole) Fluconazole Infections No data available
Lopinavir 100mg / Ritonavir 25mg tablets
0503010G0AAADAD
Lopinavir/ritonavir Lopinavir and ritonavir Infections No data available
Lopinavir 133.3mg / Ritonavir 33.3mg capsules
0503010G0AAAAAA
Lopinavir/ritonavir Lopinavir and ritonavir Infections No data available
Lopinavir 200mg / Ritonavir 50mg tablets
0503010G0AAACAC
Lopinavir/ritonavir Lopinavir and ritonavir Infections No data available
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution
0503010G0AAABAB
Lopinavir/ritonavir Lopinavir and ritonavir Infections No data available
Lysovir 100mg capsules
0503040C0BBAAAA
Lysovir Amantadine hydrochloride Infections No data available
Macrodantin 100mg capsules
0501130R0BCABAB
Macrodantin Nitrofurantoin Infections No data available
Mafamoz 250mg/100mg tablets
0504010U0BDABAA
Mafamoz Proguanil hydrochloride with atovaquone Infections No data available
Mafamoz 62.5mg/25mg tablets
0504010U0BDAAAB
Mafamoz Proguanil hydrochloride with atovaquone Infections No data available
Magnapen 250mg/250mg capsules
0501013L0BBAAAA
Magnapen Co-fluampicil(Flucloxacillin/ampicillin) Infections No data available
Magnapen 500mg powder for solution for injection vials
0501013L0BBABAB
Magnapen Co-fluampicil(Flucloxacillin/ampicillin) Infections No data available
Magnapen syrup
0501013L0BBADAD
Magnapen Co-fluampicil(Flucloxacillin/ampicillin) Infections No data available
Malarivon 80mg/5ml syrup
0504010F0BCAAAA
Malarivon Chloroquine phosphate Infections No data available
Maloprim tablets
0504010Q0BBAAAA
Maloprim Pyrimethamine with dapsone Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.